Nasal polyps are inflammatory growths along the lining of the nasal passages that can occur in patients suffering from chronic sinusitis. The symptoms of chronic sinusitis include nasal discharge, congestion, facial pain, and a loss of sense of smell.2 Nasal and sinus polyps are one of the toughest ENT issues to treat. While endoscopic sinus surgery can remove polyps and steroid sprays can help shrink polyps, studies show that 60-70% of patients will regrow polyps following surgical removal1. For this reason, research has been seeking for a way to control polyp regrowth in patients who have either just had surgery or have had multiple surgeries.
In the Operating Room
Here at ENT Consultants, our surgeons are proud to offer the Intersect line of steroid eluding implant devices to control polyp regrowth during traditional sinus surgery. These devices promote better outcomes for our polyp patients by slowly releasing a steroid known as mometasone (same steroid found in Nasonex nasal spray) while a patient is healing from their sinus surgery.
The Propel works great for the ethmoid sinuses between the eyes, while the Propel Mini fits nicely in the frontal/forehead drainage pathways. Contour was also recently developed for patients who tend to have issues with their cheek or maxillary sinuses. These devices have become a standard of care among our sinus surgeons, and many patients do not even know the devices have been used. The above implants dissolve all on their own. If you would like to know more about these implants for your upcoming surgery, please don't hesitate to ask your surgery scheduling nurse.
In the Office
And for those who have had one or more previous surgeries, we are the first ENT specialty group in Omaha and all of Nebraska to be able to offer the SINUVA in-office steroid implant device!
The SINUVA Sinus Implant is placed during a routine physician office visit. SINUVA expands in the sinus cavity delivering steroid directly to the tissue for up to 90 days. The implant softens over time and can be removed at 90 days or earlier at the physician's discretion.
"Many people suffer from recurrent nasal polyps, a debilitating condition that can greatly affect a person's life," says Dr. Medaris. "Until now, existing treatments have included repeat surgery, high-dose oral steroids, steroid rinses, nebulized steroids, steroid sprays, etc that all require ongoing patient compliance, financial resources, and risks. We are very excited to be among the first in the U.S. to offer this innovative treatment choice to our patients."
Positive data from the SINUVA Sinus Implant was supported by the results of the RESOLVE II pivotal study. The study demonstrated a reduction in polyps, nasal obstruction, congestion, a reduction in need for repeat sinus surgery, and an improvement in impaired sense of smell.2
1 DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2016;126:550-555.
2 Wynn, R. and G. Har-El (2004). "Recurrence rates after endoscopic sinus surgery for massive sinus polyposis." Laryngoscope 114(5): 811-813.